Intelligent Antibody Discovery

Technology Overview

Advancing the discovery of desirable therapeutic product candidates

Since its inception, Abeome has committed to improving the discovery mission for therapeutic monoclonal antibodies. Starting with DiSH™ and now with AbeoMouse™, Abeome continues to set new standards in the way valuable monoclonal antibodies are produced and accessed.

DiSH™ – Expression of Antibody on Hybridoma Cell Surface

Improving the product development cycle for new therapies is a constant challenge for drug discovery researchers. Abeome’s DiSH™ technology enables the rapid detection and production of highly specific monoclonal antibodies. Learn more »


Triple transgenic mouse engineered with enhanced immune response and with the ability for its affinity matured B-cells (Plasmacytes) to display on their surface the antibody each secretes. Learn more »